Adimmune Corp.

Adimmune Corp. produces and distributes high‑quality vaccines—quadrivalent flu, tetanus, Japanese encephalitis, COVID‑19 subunit (AdimrSC‑2f), H5N1—across Taiwan, U.S., China, and global markets, reinforcing its position as a leading pharmaceutical manufacturer.

Headquarters: Taiwan (TWN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

HQ: Taichung

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
4142	Adimmune Corp. Cap: 8.1B	EQUITY	TAI	TWD	TW0004142005	Active	📈